Related Experiment Videos
A modified BEP protocol: reduction of hospitalization without reducing the efficacy
1Department of Urology, Hacettepe University Medical School, Ankara, Turkey.
Urologia Internationalis
|January 1, 1997
Summary
A condensed bleomycin/etoposide/cisplatinum (BEP) chemotherapy regimen shows comparable efficacy to conventional treatment for metastatic testicular tumors. This modified protocol is cost-effective, improves patient compliance, and quality of life without increased toxicity.
Area of Science:
- Oncology
- Medical Chemotherapy
Background:
- Metastatic germ cell testicular tumors require effective treatment regimens.
- Conventional chemotherapy protocols can be lengthy and impact patient quality of life.
Purpose of the Study:
- To evaluate the efficacy and safety of a condensed bleomycin/etoposide/cisplatinum (BEP) regimen compared to conventional therapy for metastatic testicular tumors.
Main Methods:
- A modified BEP protocol was administered to 64 patients with metastatic germ cell testicular tumors.
- The condensed regimen involved a single daily dose of cisplatin (100 mg/m2) and bleomycin (30 mg), plus 3 consecutive days of etoposide (150 mg/m2).
Main Results:
- A complete response to chemotherapy alone was achieved in 54% of patients.
- An additional 35% of patients became tumor-free after surgery and further chemotherapy.
- Hospitalization duration per course was reduced, and creatinine clearances remained stable, indicating comparable toxicity.
Conclusions:
- The condensed BEP protocol appears cost-effective and enhances patient compliance and quality of life.
- Efficacy is comparable to conventional therapy without increased toxicity.
- Further prospective randomized trials are necessary to confirm these findings and potentially replace conventional therapy.